U.S. Markets closed

Tesaro, Inc. (TSRO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
126.70-3.36 (-2.58%)
At close: 4:00PM EDT

126.68 -0.02 (-0.01%)
After hours: 4:58PM EDT

People also watch
Full screen
Previous Close130.06
Bid120.00 x 100
Ask138.00 x 200
Day's Range126.20 - 133.66
52 Week Range83.26 - 192.94
Avg. Volume1,188,828
Market Cap6.82B
PE Ratio (TTM)-14.87
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals8 hours ago

    Waltham's Tesaro grabs $100M in cancer drug partnership with Takeda

    Waltham-based Tesaro is capitalizing on the early success of its new cancer drug, handing over some development and commercial rights to Takeda in a deal worth up to $340 million plus royalties. Tesaro (TSRO) said Thursday that the once-daily pill, which is marketed in the U.S. as Zejula following an FDA approval in March, will be developed and sold by Takeda in Japan, where the drug giant is headquartered. Under the deal, Takeda will get development and commercial rights in four additional countries — South Korea, Taiwan, Russia and Australia — for all kinds of tumors except prostate cancer.

  • Capital Cube2 days ago

    ETFs with exposure to TESARO, Inc. : July 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TESARO, Inc. Here are 5 ETFs with the largest exposure to TSRO-US. Comparing the performance and risk of TESARO, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Why National Beverage, Tesaro, and Community Health Systems Slumped Today
    Motley Fool14 days ago

    Why National Beverage, Tesaro, and Community Health Systems Slumped Today

    Despite a positive day for the markets, these stocks fell. Find out why.